Global Ophthalmology Drugs & Devices Market Growth 2023-2029

Global Ophthalmology Drugs & Devices Market Growth 2023-2029

Ophthalmology is a branch of medicine and surgery (both methods are used) that deals with the anatomy, physiology and diseases of the eyeball and orbit. Ophthalmic Equipment are the tool used for ophthalmology.

LPI (LP Information)' newest research report, the “Ophthalmology Drugs & Devices Industry Forecast” looks at past sales and reviews total world Ophthalmology Drugs & Devices sales in 2022, providing a comprehensive analysis by region and market sector of projected Ophthalmology Drugs & Devices sales for 2023 through 2029. With Ophthalmology Drugs & Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Ophthalmology Drugs & Devices industry.

This Insight Report provides a comprehensive analysis of the global Ophthalmology Drugs & Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Ophthalmology Drugs & Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Ophthalmology Drugs & Devices market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Ophthalmology Drugs & Devices and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Ophthalmology Drugs & Devices.

The global Ophthalmology Drugs & Devices market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

The growth of this market is primarily due to the rapid growth in the geriatric population, rising prevalence of eye diseases, technological advancements in ophthalmic devices, increasing government initiatives to control visual impairment.

This report presents a comprehensive overview, market shares, and growth opportunities of Ophthalmology Drugs & Devices market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Diagnostic and Monitoring Devices
Surgical Devices
Vision Care Product
Ophthalmology Drugs

Segmentation by application
Hospitals
Specialty Clinics
Ambulatory Surgical Centers (ASCs)

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott
Alcon
Allergan
Bausch & Lomb
Carl Zeiss Meditec
Ellex
Essilor
Hoya
Iridex
Johnson & Johnson
Merck & Co.
Nidek Co.
Santen Pharmaceutical
Novartis
Pfizer
Roche Holding
Staar Surgical
Topcon
Ziemer Ophthalmic Systems

Key Questions Addressed in this Report

What is the 10-year outlook for the global Ophthalmology Drugs & Devices market?

What factors are driving Ophthalmology Drugs & Devices market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Ophthalmology Drugs & Devices market opportunities vary by end market size?

How does Ophthalmology Drugs & Devices break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.